Ash Alizadeh, a physician at Stanford specializing in oncology, dives into the revolutionary world of liquid biopsies. He explains how this non-invasive method can detect localized cancers through blood samples, making traditional biopsies a thing of the past. Alizadeh discusses the significant genomic differences between normal and cancer DNA, and highlights advancements in technology like fragmentomics. The conversation also covers the integration of liquid biopsies with immunotherapy, paving the way for personalized cancer treatment that could transform patient outcomes.
